The Paradigm Peptides case is the biggest to rock the industry, an unregulated market which has exploded into the mainstream over the past 18 months. Another type of drug sold by Paradigm Peptides was SARMs - Selective Androgen Receptor Modulators - which target specific tissues to increase muscle and bone mass. 'UK consumers at risk'As Murphy's life spun out of control, unknown to him, the FDA was already investigating Paradigm Peptides. By September 2023, the FDA had seized SARMs products from Paradigm to carry out tests on them. Then in December 2024, Murphy ran out of his supply of Paradigm Peptides supplements.